Class 4 Medicines Defect Notification: Erythromycin Stearate BP 250mg Tablets, Amdipharm UK Ltd, EL(25)A/32

Sign up for your FREE ticket to see PharmData at the Pharmacy Show to see our latest products and features demonstrated live!

Class 4 Medicines Defect Notification: Erythromycin Stearate BP 250mg Tablets, Amdipharm UK Ltd, EL(25)A/32

2025-07-01 09:59:36 (2 month(s) ago)

Summary

Amdipharm UK Ltd has informed MHRA that the Patient information leaflet (PIL) in the cartons for the batch listed in this notification includes a superseded PIL.

Read full MHRA article

Respond to this alert